ELVElevance Health, Inc.
- Next report
- No date yet
- none in the next 8 weeks
- Last result
- $6.99Beat
- vs $4.66 expected on Oct 21
- Stock move on it
- −1.37%
- one session
- Typical move
- ±2.9%
- average over 2 reports
- Price
- $430.01
- +0.12% today · $81.5B cap
Past and upcoming reports
2
| Oct 21, 2026 | Sep 30, 2026 | Time not given | $4.66 | Beat$6.99 | −1.37% |
| Jul 16, 2026 | Jun 30, 2026 | Time not given | $6.20 | Beat$7.45 | −4.41%2d |
After the report
Jul 16, 2026 report
This covers the Jul 16, 2026 report. The Oct 21, 2026 numbers are in the table above.
ELV EPS +20.6% beat but margin fears cap gains
Elevance Health reported Q2 EPS of $7.45, beating estimates by $1.27 (+20.6%). Despite the big beat, the stock edged up only 0.07% on the day and had fallen sharply in prior sessions, suggesting market focus remains on medical cost trends and margin pressure.
Reported against expected
BeatEPS of $7.45 vs estimated $6.18, a beat of 20.6%.
Guidance
No guidance raise. management commentary highlights medical cost pressure, signaling caution.
How the stock reacted
Stock closed at $373.11, up 0.07% on the day, but follows two prior sessions of steep declines (-8.65% and -4.5%) indicating early negative reaction.
What changed
EPS beat by 20.6% yet margins dominate market focus.
What the price now assumes
Margin and medical cost risk over short-term earnings power.
What it means for the business
Maintain constructive. monitor Q3 medical cost ratio for thesis validation.
The next one to three months, as we saw it then
Better case30%
Margin fears prove overblown. EPS strength continues, valuation re-rates toward $449 analyst target.
Base case50%
Current valuations hold. EPS growth moderates but margins stabilize.
Worse case20%
Medical costs continue to rise, forcing margin compression and guidance cuts.
If you hold it
Hold unless next-quarter revenue misses guidance materially or customer concentration risk worsens.
If you are watching
Add only if next-quarter guidance is reiterated or raised. avoid if guidance is cut or geopolitical risk escalates.
Scenario odds are a judgement, not measured.